A Quantitative System for Discriminating Induced Pluripotent Stem Cells, Embryonic Stem Cells and Somatic Cells

Wang, Anyou; Du, Ying; He, Qianchuan; Zhou, Chunxiao
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Induced pluripotent stem cells (iPSCs) derived from somatic cells (SCs) and embryonic stem cells (ESCs) provide promising resources for regenerative medicine and medical research, leading to a daily identification of new cell lines. However, an efficient system to discriminate the different types of cell lines is lacking. Here, we develop a quantitative system to discriminate the three cell types, iPSCs, ESCs, and SCs. The system consists of DNA-methylation biomarkers and mathematical models, including an artificial neural network and support vector machines. All biomarkers were unbiasedly selected by calculating an eigengene score derived from analysis of genome-wide DNA methylations. With 30 biomarkers, or even with as few as 3 top biomarkers, this system can discriminate SCs from pluripotent cells (PCs, including ESCs and iPSCs) with almost 100% accuracy. With approximately 100 biomarkers, the system can distinguish ESCs from iPSCs with an accuracy of 95%. This robust system performs precisely with raw data without normalization as well as with converted data in which the continuous methylation levels are accounted. Strikingly, this system can even accurately predict new samples generated from different microarray platforms and the next-generation sequencing. The subtypes of cells, such as female and male iPSCs and fetal and adult SCs, can also be discriminated with this method. Thus, this novel quantitative system works as an accurate framework for discriminating the three cell types, iPSCs, ESCs, and SCs. This strategy also supports the notion that DNA-methylation generally varies among the three cell types.


Related Articles

  • Abnormalities in human pluripotent cells due to reprogramming mechanisms. Ma, Hong; Morey, Robert; O'Neil, Ryan C.; He, Yupeng; Daughtry, Brittany; Schultz, Matthew D.; Hariharan, Manoj; Nery, Joseph R.; Castanon, Rosa; Sabatini, Karen; Thiagarajan, Rathi D.; Tachibana, Masahito; Kang, Eunju; Tippner-Hedges, Rebecca; Ahmed, Riffat; Gutierrez, Nuria Marti; Van Dyken, Crystal; Polat, Alim; Sugawara, Atsushi; Sparman, Michelle // Nature;7/10/2014, Vol. 511 Issue 7508, p177 

    Human pluripotent stem cells hold potential for regenerative medicine, but available cell types have significant limitations. Although embryonic stem cells (ES cells) from in vitro fertilized embryos (IVF ES cells) represent the 'gold standard', they are allogeneic to patients. Autologous...

  • Session 53: Are human embryonic stem cells ready for regenerative medicine?  // Human Reproduction;Jun2013, Vol. 28 Issue suppl_1, pi84 

    No abstract available.

  • Experimental approaches for the generation of induced pluripotent stem cells. Sommer, Cesar A.; Mostoslavsky, Gustavo // Stem Cell Research & Therapy; 

    Derivation of autologous induced pluripotent stem cells (iPSCs) through direct reprogramming of easily accessible somatic cells holds the potential to transform the field of regenerative medicine. Since Takahashi and Yamanaka's groundbreaking study describing the generation of iPSCs by...

  • Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Wu, Sean M.; Hochedlinger, Konrad // Nature Cell Biology;May2011, Vol. 13 Issue 5, p497 

    The discovery of methods to convert somatic cells into induced pluripotent stem cells (iPSCs) through expression of a small combination of transcription factors has raised the possibility of producing custom-tailored cells for the study and treatment of numerous diseases. Indeed, iPSCs have...

  • Direct reprogramming of adult cells: avoiding the pluripotent state. Kelaini, Sophia; Cochrane, Amy; Margariti, Andriana // Stem Cells & Cloning: Advances & Applications;2014, Vol. 7, p19 

    The procedure of using mature, fully differentiated cells and inducing them toward other cell types while bypassing an intermediate pluripotent state is termed direct reprogramming. Avoiding the pluripotent stage during cellular conversions can be achieved either through ectopic expression of...

  • The cell cycle and pluripotency. HINDLEY, Christopher; PHILPOTT, Anna // Biochemical Journal;4/15/2013, Vol. 451 Issue 2, p135 

    PSCs (pluripotent stem cells) possess two key properties that have made them the focus of global research efforts in regenerative medicine: they have unlimited expansion potential under conditions which favour their preservation as PSCs and they have the ability to generate all somatic cell...

  • Epigenetic Control of Embryonic Stem Cell Differentiation. Armstrong, Lyle // Stem Cell Reviews & Reports;Mar2012, Vol. 8 Issue 1, p67 

    Pluripotent embryonic stem cells can give rise to almost all somatic cell types but this characteristic requires precise control of their gene expression patterns. The necessity of keeping the entire genome 'poised' to enter into any of a number of developmental possibilities requires a unique...

  • Defining Hypo-Methylated Regions of Stem Cell-Specific Promoters in Human iPS Cells Derived from Extra-Embryonic Amnions and Lung Fibroblasts. Nishino, Koichiro; Toyoda, Masashi; Yamazaki-Inoue, Mayu; Makino, Hatsune; Fukawatase, Yoshihiro; Chikazawa, Emi; Takahashi, Yoriko; Miyagawa, Yoshitaka; Okita, Hajime; Kiyokawa, Nobutaka; Akutsu, Hidenori; Umezawa, Akihiro // PLoS ONE;2010, Vol. 5 Issue 9, p1 

    Background: Human induced pluripotent stem (iPS) cells are currently used as powerful resources in regenerative medicine. During very early developmental stages, DNA methylation decreases to an overall low level at the blastocyst stage, from which embryonic stem cells are derived.Therefore,...

  • Efficient and Directive Generation of Two Distinct Endoderm Lineages from Human ESCs and iPSCs by Differentiation Stage-Specific SOX17 Transduction. Takayama, Kazuo; Inamura, Mitsuru; Kawabata, Kenji; Tashiro, Katsuhisa; Katayama, Kazufumi; Sakurai, Fuminori; Hayakawa, Takao; Furue, Miho Kusuda; Mizuguchi, Hiroyuki // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    The establishment of methods for directive differentiation from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) is important for regenerative medicine. Although Sry-related HMG box 17 (SOX17) overexpression in ESCs leads to differentiation of either extraembryonic or...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics